Amgen Profile

194.88
USD 2.08  1.08%
91%
31%

Sale by Sharer Kevin W of 4100 shares of Amgen

Amgen insider trading alert for sale of common stock by Sharer Kevin W, Chairman of the Bd CEO Pres, on July 17, 2018. This event was filed by Amgen Inc with SEC on 2005-11-10. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Amgen Summary

Amgen (AMGN) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with current market capitalization of 129.63 B. Amgen conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 661.71 M outstanding shares of which 10.61 M shares are presently shorted by private and institutional investors with about 3.61 trading days to cover. AMGEN currently holds about 32.17 B in cash with 8.46 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 48.62.
Check Amgen Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 194.88HorizonTargetOdds Above 194.88
90.59%30 days 194.88 9.22%
Based on normal probability distribution, the odds of Amgen to move above current price in 30 days from now is about 9.22% (This Amgen probability density function shows the probability of Amgen Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Bank Of MontrealCommon Shares2.1 M379 M
Nn Investment Partners Holdings NvCommon Shares567.2 K104.7 M
View Amgen Diagnostics

Selected Amgen Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Amgen Against Markets

Risk Adjusted
Performance Score (0 to 100)
14 
Chance of
Financial Distress (0 to 100%)
28 
Equity ratings for Amgen are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Amgen SEC Filings
Amgen SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAmgen
ChairmanRobert BradwayView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 6 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
RegionNorth America
LocationCALIFORNIA U.S.A
Business AddressOne Amgen Center Drive
Foreign Associates
ExchangeBATS Exchange
CIK Number0000318154
ISINUS0311621009
CUSIP311621007
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.amgen.com
Phone805 447 1000
CurrencyUSD - US Dollar

Current Sentiment - AMGN

Amgen Investor Sentiment
Majority of Macroaxis users are presently bullish on Amgen. What is your sentiment towards investing in Amgen? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Amgen Corporate Directors

Frank Herringer Independent Director
Francois Carbonnel Independent Director
Rebecca Henderson Independent Director, Ph.D
Check also Trending Equities. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.